Unraveling the underlying molecular mechanisms which regulate the lymphoid phenotype and lymphoid maturation is crucial for our understanding of immune function. POU domain proteins have been found to be critical for development and maintenance of the mature phenotype of specific lineages. POU proteins affect development be regulating lineage specific gene expression via athe octamer or octamer related motifs. Mutation of POU genes affects this interaction and leads to aberrations in development of specific lineages. The importance of octamer and octamer like motifs in lymphocyte specific gene expression is well documented. The known lymphoid POU proteins can not satisfactorily explain most of the octamer dependent lymphoid specific gene expression. We have identified a novel lymphoid POU protein, TCFbeta1 which is distantly related to other known POU proteins. We propose here experiments designed to reveal its function in mature lymphoid cells and during T cell development. This will involve determining the effect of abrogation of TCFbeta1 activity on the lymphoid phenotype. In particular studies are described which address its role in regulating the Calcium sensitive signaling pathway in Il2 gene expression. We will also be involved with abrogate TCFbeta1 activity in thymus of transgenic mice in order to understand athe role of TCFbeta1 in T cell development. They will clarify the comparative roles of three different lymphoid POU domain proteins in T cell development. These studies will help generate tissue culture and mouse models of immune dysfunction which help in elucidating lymphocyte development and function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI031453-04
Application #
2672069
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1995-08-01
Project End
2000-07-31
Budget Start
1998-08-01
Budget End
1999-07-31
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Sidney Kimmel Cancer Center
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92121
Jung, Barbara; Barbier, Valerie; Brickner, Howard et al. (2005) Mechanisms of sulindac-induced apoptosis and cell cycle arrest. Cancer Lett 219:15-25
Pennaneach, V; Salles-Passador, I; Munshi, A et al. (2001) The large subunit of replication factor C promotes cell survival after DNA damage in an LxCxE motif- and Rb-dependent manner. Mol Cell 7:715-27
Boulaire, J; Fotedar, A; Fotedar, R (2000) The functions of the cdk-cyclin kinase inhibitor p21WAF1. Pathol Biol (Paris) 48:190-202
Rousseau, D; Cannella, D; Boulaire, J et al. (1999) Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway. Oncogene 18:3290-302
Rousseau, D; Cannella, D; Boulaire, J et al. (1999) Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway. Oncogene 18:4313-25
Salles-Passador, I; Fotedar, A; Fotedar, R (1999) Cellular response to DNA damage. Link between p53 and DNA-PK. C R Acad Sci III 322:113-20
Fotedar, R; Brickner, H; Saadatmandi, N et al. (1999) Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells. Oncogene 18:3652-8
Diederich, L; Fotedar, A; Fotedar, R (1998) Proteolytic cleavage of retinoblastoma protein upon DNA damage and Fas-mediated apoptosis. Cell Biol Toxicol 14:133-40
Fotedar, R; Fitzgerald, P; Rousselle, T et al. (1996) p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity. Oncogene 12:2155-64
Fotedar, R; Mossi, R; Fitzgerald, P et al. (1996) A conserved domain of the large subunit of replication factor C binds PCNA and acts like a dominant negative inhibitor of DNA replication in mammalian cells. EMBO J 15:4423-33

Showing the most recent 10 out of 11 publications